Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.

MLA

Harding, James J., et al. “Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.” Cancer Discovery, vol. 8, no. 12, Dec. 2018, pp. 1540–47. EBSCOhost, https://doi.org/10.1158/2159-8290.CD-18-0877.

APA

Harding, J. J., Lowery, M. A., Shih, A. H., Schvartzman, J. M., Hou, S., Famulare, C., Patel, M., Roshal, M., Do, R. K., Zehir, A., You, D., Selcuklu, S. D., Viale, A., Tallman, M. S., Hyman, D. M., Reznik, E., Finley, L. W. S., Papaemmanuil, E., Tosolini, A., … Intlekofer, A. M. (2018). Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition. Cancer Discovery, 8(12), 1540–1547. https://doi.org/10.1158/2159-8290.CD-18-0877

Chicago

Harding, James J, Maeve A Lowery, Alan H Shih, Juan M Schvartzman, Shengqi Hou, Christopher Famulare, Minal Patel, et al. 2018. “Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.” Cancer Discovery 8 (12): 1540–47. doi:10.1158/2159-8290.CD-18-0877.